2021 ASCO Annual Meeting: Reports on Kidney, Esophageal, and Cervical Cancers

We’re continuing our coverage of Plenary presentations from the 2021 ASCO Annual Meeting, including research on adjuvant pembrolizumab for patients with renal cell carcinoma; novel treatment options for advanced esophageal squamous cell carcinoma; and adjuvant chemotherapy given after standard cisplatin-based chemoradiation for women with locally advanced cervical cancer.

---